Listen To The Lancet Gastroenterology & Hepatology

In conversation with... Arndt Vogel

Informações:

Synopsis

Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies.